Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Clinical Investigation

• Publication date

  1997-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI119757PMID 9410897PMCID PMC508415
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains.

  1996cited by this paper
• Analysis of Alternative Splicing Patterns in the Cystic Fibrosis Transmembrane Conductance Regulator Gene Using mRNA Derived from Lymphoblastoid Cells of Cystic Fibrosis Patients

  1996cited by this paper
• Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence.

  1996cited by this paper
• Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.

  1996cited by this paper
• A complex of nuclear proteins mediates SR protein binding to a purine-rich splicing enhancer.

  1996cited by this paper
• Seven Novel Additional Small Mutations and a New Alternative Splicing in the Human Dystrophin Gene Detected by Heteroduplex Analysis and Restricted RT-PCR Heteroduplex Analysis of Illegitimate Transcripts

  1996cited by this paper
• A Novel Nonsense Mutation Associated with an Exon Skipping in a Patient with Hereditary Protein S Deficiency Type I

  1996cited by this paper
• Duchenne/Becker muscular dystrophy: from molecular diagnosis to gene therapy.

  1996cited by this paper
• Nonsense mutations in a Becker muscular dystrophy and an intermediate patient

  1996cited by this paper
• The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.

  1995cited by this paper
• Transcript analysis of CFTR nonsense mutations in lymphocytes and nasal epithelial cells from cystic fibrosis patients

  1995cited by this paper
• Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe.

  1995cited by this paper
• Synergistic interactions between two distinct elements of a regulated splicing enhancer.

  1995cited by this paper
• When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells.

  1995cited by this paper
• Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA.

  1995cited by this paper
• A novel point mutation (G-1 to T) in a 5' splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy.

  1994cited by this paper
• Maintenance of an open reading frame as an additional level of scrutiny during splice site selection

  1994cited by this paper
• A splicing enhancer exhibits both constitutive and regulated activities.

  1994cited by this paper
• Polypurine sequences within a downstream exon function as a splicing enhancer

  1994influential reference
• The stop mutation R553X in the CFTR gene results in exon skipping.

  1994cited by this paper
• Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter.

  1994cited by this paper
• Diverse mutations in patients with Menkes disease often lead to exon skipping.

  1994cited by this paper
• Molecular analysis of Hurler syndrome in Druze and Muslim Arab patients in Israel: multiple allelic mutations of the IDUA gene in a small geographic area.

  1993cited by this paper
• Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patients.

  1993cited by this paper
• A nonsense mutation and exon skipping in the Fanconi anaemia group C gene.

  1993cited by this paper
• The skipping of constitutive exons in vivo induced by nonsense mutations

  1993influential reference
• The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element

  1993cited by this paper
• Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect.

  1993cited by this paper
• The structural and functional diversity of dystrophin

  1993cited by this paper
• Insertion of a 5' truncated L1 element into the 3' end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy.

  1993cited by this paper
• The role of exon sequences in splice site selection.

  1993cited by this paper
• Point mutations in the dystrophin gene.

  1992cited by this paper
• The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences

  1992cited by this paper
• Selective amplification of cDNA sequence from total RNA by cassette-ligation mediated polymerase chain reaction (PCR): application to sequencing 6.5 kb genome segment of hantavirus strain B-1.

  1992cited by this paper
• Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene.

  1992cited by this paper
• Dystrophin is transcribed in brain from a distant upstream promoter.

  1991cited by this paper
• Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe.

  1991cited by this paper
• Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction

  1990cited by this paper
• 33 – MULTIPLEX PCR FOR THE DIAGNOSIS OF DUCHENNE MUSCULAR DYSTROPHY

  1990cited by this paper
• An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.

  1988influential reference
• The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein.

  1988influential reference
• RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression.

  1987cited by this paper
• Pre-mRNA splicing.

  1986cited by this paper

• Diversity of mutations in the dystrophin gene and details of muscular lesions in porcine dystrophinopathies

  2023cites this paper
• Evidence in disease and non-disease contexts that nonsense mutations cause altered splicing via motif disruption

  2021cites this paper
• CPAA_A_288842 235..242

  2021cites this paper
• Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience

  2021cites this paper
• A genome-wide association analysis of loss of ambulation in dystrophinopathy patients suggests multiple candidate modifiers of disease severity

  2021cites this paper
• RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing

  2021cites this paper
• Antisense Oligonucleotide-Mediated Exon-skipping Therapies: Precision Medicine Spreading from Duchenne Muscular Dystrophy

  2021cites this paper
• Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy

  2020cites this paper
• The position of nonsense mutations can predict the phenotype severity: A survey on the DMD gene

  2020cites this paper
• Skipping Nonsense to Maintain Function: The Paradigm of BRCA2 Exon 12

  2020cites this paper
• Mutations primarily alter the inclusion of alternatively spliced exons

  2020cites this paper
• Skipping of an exon with a nonsense mutation in the DMD gene is induced by the conversion of a splicing enhancer to a splicing silencer

  2019cites this paper
• Aberrant RNA splicing is the major pathogenic effect in a knock‐in mouse model of the dominantly inherited c.1430A>G human RPE65 mutation

  2019cites this paper
• Mutational spectrum of dystrophinopathies in Singapore: Insights for genetic diagnosis and precision therapy

  2019cites this paper
• AON-Mediated Exon Skipping to Bypass Protein Truncation in Retinal Dystrophies Due to the Recurrent CEP290 c.4723A > T Mutation. Fact or Fiction?

  2019cites this paper
• Basal exon skipping and nonsense-associated altered splicing allows bypassing complete CEP290 loss-of-function in individuals with unusually mild retinal disease

  2018cites this paper
• MODULATION OF EXON RECOGNITION IN PRE-MRNABY INTERFERING WITH THE SECONDARY RNASTRUCTURE

  2017cites this paper
• Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan

  2017cites this paper
• Low-level dystrophin expression attenuating the dystrophinopathy phenotype.

  2017cites this paper
• Normal and altered pre-mRNA processing in the DMD gene

  2017cites this paper
• Dystrophin Exon 29 Nonsense Mutations Cause a Variably Mild Phenotype

  2017cites this paper
• Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy

  2016cites this paper
• Contributions of Japanese patients to development of antisense therapy for DMD.

  2016cites this paper
• Alternative Splicing, Internal Promoter, Nonsense-Mediated Decay, or All Three

  2016cites this paper
• Translational Research on DMD in Japan

  2016cites this paper
• Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy

  2016cites this paper
• Staurosporine allows dystrophin expression by skipping of nonsense-encoding exon.

  2016cites this paper
• Investigational treatments and therapeutic targets in Becker muscular dystrophy

  2015cites this paper
• FUBP1: a new protagonist in splicing regulation of the DMD gene

  2015cites this paper
• Chapter 30 – Dystrophinopathies

  2015cites this paper
• The Human IL-23 Receptor rs11209026 A Allele Promotes the Expression of a Soluble IL-23R–Encoding mRNA Species

  2015cites this paper
• A commentary on a novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy

  2014cites this paper
• Engineering specificity changes on a RanBP2 zinc finger that binds single-stranded RNA.

  2014cites this paper
• Early Progressive Dilated Cardiomyopathy in a Family with Becker Muscular Dystrophy Related to a Novel Frameshift Mutation in the Dystrophin Gene Exon 27

  2014cites this paper
• When a mid-intronic variation of DMD gene creates an ESE site.

  2014cites this paper
• A novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy

  2014cites this paper
• The medical genetics of dystrophinopathies: molecular genetic diagnosis and its impact on clinical practice.

  2013cites this paper
• Analysis of the Intranuclear Life of Nonsense Transcripts

  2013cites this paper
• Interplay between DMD Point Mutations and Splicing Signals in Dystrophinopathy Phenotypes

  2013cites this paper
• Analysis of aberrant splicing and nonsense-mediated decay of the stop codon mutations c.109G>T and c.504_505delCT in 7 patients with HMG-CoA lyase deficiency.

  2013cites this paper
• Mutation Spectrum of Dystrophin Gene in Malaysian Patients with Duchenne/Becker Muscular Dystrophy

  2013cites this paper
• Optimizing RNA/ENA chimeric antisense oligonucleotides using in vitro splicing.

  2012cites this paper
• Nonsense-Associated Alternative Splicing of the Human Thyroglobulin Gene

  2012cites this paper
• Exon Skipping

  2012cites this paper
• Unspliced Precursors of NMD-Sensitive β-Globin Transcripts Exhibit Decreased Steady-State Levels in Erythroid Cells

  2012cites this paper
• Categorization of 77 dystrophin exons into 5 groups by a decision tree using indexes of splicing regulatory factors as decision markers

  2012cites this paper
• Molecular characterization of an X(p21.2;q28) chromosomal inversion in a Duchenne muscular dystrophy patient with mental retardation reveals a novel long non-coding gene on Xq28

  2012cites this paper
• A G-to-T Transversion at the Splice Acceptor Site of Dystrophin Exon 14 Shows Multiple Splicing Outcomes That Are Not Exemplified by Transition Mutations

  2012cites this paper
• [Treatment with antisense oligonucleotides in Duchenne's disease].

  2012cites this paper
• Antisense Oligonucleotide Induced Dystrophin Exon 45 Skipping at a Low Half-Maximal Effective Concentration in a Cell-Free Splicing System

  2011cites this paper
• Nonsense mutation‐associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene

  2011influential citation
• Loss of exon identity is a common mechanism of human inherited disease.

  2011cites this paper
• Chemical treatment enhances skipping of a mutated exon in the dystrophin gene

  2011cites this paper
• Splicing aberrations caused by constitutional RB1 gene mutations in retinoblastoma

  2011cites this paper
• RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes.

  2011cites this paper
• Two closely spaced nonsense mutations in the DMD gene in a Malaysian family.

  2011cites this paper
• Přírodovědecká fakulta Ústav experimentální biologie Oddělení genetiky a molekulární biologie

  2011cites this paper
• Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center

  2010cites this paper
• Personalized exon skipping strategies to address clustered non-deletion dystrophin mutations.

  2010cites this paper
• Transposable elements in disease-associated cryptic exons

  2010cites this paper
• Identification of Small Molecule and Genetic Modulators of AON-Induced Dystrophin Exon Skipping by High-Throughput Screening

  2009cites this paper
• Small Mutations Detected by Multiplex Ligation-Dependent Probe Amplification of the Dystrophin Gene

  2009cites this paper
• AWARD NUMBER: W81XWH-07-1-0380 TITLE: A Functional Assay for Allele-Specific BRCA 1/2 mRNA Null Phenotypes in Breast/Ovarian Cancer Families

  2009cites this paper
• OCRL1 Mutations in Dent 2 Patients Suggest a Mechanism for Phenotypic Variability

  2009cites this paper
• Hematopoietic Cell Transplantation Provides an Immune-tolerant Platform for Myoblast Transplantation in Dystrophic Dogs

  2008cites this paper
• Nonsense‐associated altered splicing of the Patched gene fails to suppress carcinogenesis in Gorlin syndrome

  2008cites this paper
• Missense and nonsense mutations in the alternatively‐spliced exon 2 of COL2A1 cause the ocular variant of Stickler syndrome

  2008cites this paper
• Dystrophin Nonsense Mutations Can Generate Alternative Rescue Transcripts in Lymphocytes

  2008influential citation
• Splicing fidelity, enhancers, and disease.

  2008cites this paper
• Two novel missense mutations in the myostatin gene identified in Japanese patients with Duchenne muscular dystrophy

  2007cites this paper
• Interplay between Exonic Splicing Enhancers, mRNA Processing, and mRNA Surveillance in the Dystrophic Mdx Mouse

  2007cites this paper
• A prospective randomized comparative study of the effects of intranasal and transdermal 17 β-estradiol on postmenopausal symptoms and vaginal cytology

  2007cites this paper
• Detection of a Transcript Abnormality in mRNA of the SLC12A3 Gene Extracted From Urinary Sediment Cells of a Patient With Gitelman's Syndrome

  2007cites this paper
• The Cold, Hard Truth About Pediatric Research

  2007cites this paper
• Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications.

  2007cites this paper
• Molecular genetics of Stickler and Marshall syndromes, and the role of collagen II and other candidate proteins in high myopia and impaired hearing

  2007cites this paper
• One gene, many phenotypes.

  2007cites this paper
• Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons

  2007cites this paper
• Modification of pre-mRNA processing: application to dystrophin expression.

  2006cites this paper
• Novel cryptic exons identified in introns 2 and 3 of the human dystrophin gene with duplication of exons 8-11.

  2006cites this paper
• A nonsense mutation-created intraexonic splice site is active in the lymphocytes, but not in the skeletal muscle of a DMD patient

  2006cites this paper
• An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.

  2006cites this paper
• Intravenous Infusion of an Antisense Oligonucleotide Results in Exon Skipping in Muscle Dystrophin mRNA of Duchenne Muscular Dystrophy

  2006cites this paper
• Mild Nijmegen breakage syndrome phenotype due to alternative splicing.

  2006cites this paper
• Splicing analysis disclosed a determinant single nucleotide for exon skipping caused by a novel intraexonic four-nucleotide deletion in the dystrophin gene

  2006cites this paper
• Redirecting splicing to address dystrophin mutations: molecular by-pass surgery.

  2006cites this paper
• Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide

  2006cites this paper
• Exonic Splicing Enhancers

  2006cites this paper
• RNA splicing manipulation: strategies to modify gene expression for a variety of therapeutic outcomes.

  2005cites this paper
• Disruption of an exon splicing enhancer in exon 3 of MLH1 is the cause of HNPCC in a Quebec family

  2005cites this paper
• Biomedical and Veterinary Sciences

  2005cites this paper
• Automated splicing mutation analysis by information theory

  2005cites this paper
• A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.

  2005cites this paper
• Synonymous SNPs Provide Evidence for Selective Constraint on Human Exonic Splicing Enhancers

  2005cites this paper
• Mutation spectrum leading to an attenuated phenotype in dystrophinopathies

  2005cites this paper
• C-Terminal Truncated Dystrophin Identified in Skeletal Muscle of an Asymptomatic Boy with a Novel Nonsense Mutation of the Dystrophin Gene

  2004cites this paper
• Chimeric RNA/Ethylene-Bridged Nucleic Acids Promote Dystrophin Expression in Myocytes of Duchenne Muscular Dystrophy by Inducing Skipping of the Nonsense Mutation-Encoding Exon

  2004cites this paper
• Regulation of Alternative RNA Splicing by Exon Definition and Exon Sequences in Viral and Mammalian Gene Expression

  2004cites this paper
• Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1333 Strategies for Identification of Susceptibility Genes in Complex Autoimmune Diseases

  2004cites this paper
• DGGE‐based whole‐gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients

  2004cites this paper